Home > Federal Affairs
Integrated Healthcare Policy Consortium /Legislative Priorities / Legislative Action Center / National Plan / National Policy Dialogue /
NCCAM / White House Commission / Email Alert


AAHF lobbies at the federal level for legislation that increases consumers' health care freedom and access to alternative therapies. We work to protect patient rights through legislation, regulation and the courts.

AAHF Board Member and former Congressman Berkly Bedell testifies on the Access to Medical Treatment Act in hearings of the House Government Reform and Oversight Committee in February 1998. Seated behind him are Former AAHF Executive Director Candace Campbell and health freedom activist Maury Silverman.
The Integrated Healthcare Policy Consortium
A National Working Group of the Collaboration for Healthcare Renewal Foundation

Legislative Priorities for the 108th Congress

Our main priority for this Congress is passage of the Access to Medical Treatment Act HR 2085/SB 1410, however we are following a number of other bills, amendments and proposed regulations. For instance we are closely following the U.S. Food and Drug Administration’s efforts to draft regulations on health claims for dietary supplements. We have also filed comments on the agency’s proposed regulations regarding the definition of disease.

FDA’s Ban On Dietary Supplements With Ephedrine Alkaloids

The Food and Drug Administration's (FDA) action on December 30th is no surprise, we knew it was coming, according to the AAHF's Washington Lobbyist, Lee Bechtel. What is a surprise is that the FDA’s ruling is broader than what has and is being portrayed in the press, and of course by the FDA. The impact on future access to safe and effective dietary supplements could be hugh, if and when the final regulation is implemented and enforced.

The notice to consumers and dietary supplement manufacturers and distributors on issuing a final rule, effective after a 60 day Congressional review period, will prohibit the sale of any and all dietary supplements containing ephedrine alkaloids, not just individual products containing ephedra.

The rule will not pertain to traditional Chinese herbal remedies or to products like herbal teas. The FDA has sent 62 letters to firms marketing dietary supplements containing ephedra and ephedrine alkaloids alerting them of this future rule.

On the positive side, the FDA Commissioner is quoted as saying that the agency is "going to issue a rule that clarifies and applies a legal standard that has never been used before". This regulation will be the first time ever that the standards in the dietary supplement law, DSHEA, now ten years old, have been used to impose major restrictions on the sale of dietary supplements.

Two Congressional Resolutions, House Resolution 435 and Senate Resolution 260, which support this FDA action, have already been introduced. When Congress returns after January 20, 2004, it is very likely that these will quickly be brought up for passage.

Please click here to download the PDF (300k) that includes:

  • FDA Press Release
  • What The Ban Entails With Questions & Answers Concerning The FDA Action
  • The FDA Consumer Alert
  • The Representative FDA Letter Sent To Manufacturers
  • The List Of Manufacturers Receiving The Notice

Legislative Action Center

Visit our Legislative Action Center for specific information about legislation we are following and more. Read action alerts, track key votes, get information about Members of Congress, find committee assignments, learn Capitol Hill basics, even access a media guide, all searchable by state or zip code.

National Plan to Advance Integrated Health Care

We have prepared the following National Plan to Advance Integrated Health Care, in order to help focus the health care debate in the coming millennium.

National Center for Complementary and Alternative Medicine

AAHF led the effort to achieve passage of NCCAM, which became law in October 1998.

White House Commission on Complementary and Alternative Medicine Policy

As you may know, AAHF was instrumental in creating the White House Commission on Complementary and Alternative Medicine Policy several years ago, in an effort to direct the Federal Government's attention to the advancement and integration of CAM in the U.S. health care system.

National Policy Dialogue to Advance Integrated Health Care: Finding Common Ground

October 31-November 3, 2001 Washington, D.C.
The National Policy Dialogue to Advance Integrated Health Care: Finding Common Ground

October 31-November 3, 2001, Washington, D.C.
On behalf of AAHF, Candace Campbell served on the Steering Committee of the Integrated Healthcare Consortium that was established to create this summit-style event. The Committee members believe that the development of an integrated healthcare system demands the thoughtful, collaborative attention of representatives from both conventional and alternative/complementary disciplines. The purpose of the meeting was to identify common ground as well as specific activities we could undertake together to reach shared goals. Program Description

Copyright © 2001
American Association for Health Freedom
9912 Georgetown Pike Suite D-2 • P.O. Box 458 • Great Falls, Virginia • 22066
800-230-2762 • 703-759-0662 • Fax 703-759-6711
email: healthfreedom2000@yahoo.com